Evidence map›Paper›PMID 33803559›Full record

ArticleMicroorganisms2021

An Actinobacterial Isolate,

Tien-Lin Chang, Tzu-Wen Huang, Ying-Xuan Wang, Chang-Pan Liu, Ralph Kirby, Chien-Ming Chu, Chih-Hung Huang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Antibiotics (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Article
  5. Isolation ofInternational journal of microbiology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Frontiers in microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tien-Lin ChangGraduate Institution of Engineering Technology-Doctoral Department, National Taipei University of Technology, Taipei 10608, Taiwan.ORCID 0000-0003-3151-7216
Tzu-Wen HuangDepartment of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0002-1229-1138
Ying-Xuan WangInstitute of Biochemical and Biomedical Engineering, Department of Chemical Engineering and Biotechnology, National Taipei University of Technology, Taipei 10608, Taiwan.
Chang-Pan LiuDivision of Infectious Diseases, Department of Medicine, MacKay Memorial Hospital, Taipei 10491, Taiwan.
Ralph KirbyDepartment of Life Sciences and Institute of Genome Sciences, School of Life Sciences, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.
Chien-Ming ChuGraduate Institution of Engineering Technology-Doctoral Department, National Taipei University of Technology, Taipei 10608, Taiwan.
Chih-Hung HuangInstitute of Biochemical and Biomedical Engineering, Department of Chemical Engineering and Biotechnology, National Taipei University of Technology, Taipei 10608, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The need for new antibiotics is increasing due to their overuse, and antibiotic resistance has become one of the major threats worldwide to public health, food safety, and clinical treatment. In this study, we describe an actinobacterial isolate, YX44, which belongs to the genus

Indexed as

antibiotichydrophilicmultidrug-resistant Staphylococcus aureuspH stabilityStreptomyces

Identifiers

PMID33803559
PMCPMC8002889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.